Bone loss treatment, pseudoarthrosis, arthrodesis and benign tumors using xenoimplant: clinical study
Por:
Castillo, JFCD, Valdes-Gutierrez, GA, Elizondo-Vazquez, F, Perez-Ortiz, O, Barba, MCP, Leon-Mancilla, BH
Publicada:
1 jul 2009
Categoría:
Surgery
Resumen:
Background: Bone loss as a result of arthrodesis, pseudarthrosis, benign tumors and bone defects was treated using a xenoimplant (Nukbone). Methods: The effectiveness of the material was evaluated through a longitudinal and observational study at the Hospital Regional "General Ignacio Zaragoza" (HRGIZ) ISSSTE. The Mexican xenoimplant is a patent of the National Autonomous University of Mexico (UNAM). Results: Fifty two patients were considered regardless of age or gender. Of these patients, 28 were male and 24 female. Average age of the patients was 47.7 years (9-84 years). Twenty eight patients had arthrodesis, 16 were treated with pseudarthrosis, three patients had benign tumors and five patients presented bone defects, which were implanted with Nukbone at the site and was the correct treatment for the problem. The xenoimplant is fully integrated during a period of 3-18 months, depending on the size of the pathology and the region where it was placed. Fracture healing was evaluated r
Filiaciones:
Castillo, JFCD:
Hosp Reg Gen Ignacio Zaragoza, Serv Ortopedia, ISSSTE, Mexico City, DF, Mexico
Valdes-Gutierrez, GA:
Hosp Reg Gen Ignacio Zaragoza, Serv Ortopedia, ISSSTE, Mexico City, DF, Mexico
Elizondo-Vazquez, F:
Hosp Reg Gen Ignacio Zaragoza, Serv Ortopedia, ISSSTE, Mexico City, DF, Mexico
Perez-Ortiz, O:
Hosp Reg Gen Ignacio Zaragoza, Serv Ortopedia, ISSSTE, Mexico City, DF, Mexico
Barba, MCP:
Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City 04510, DF, Mexico
Leon-Mancilla, BH:
Univ Nacl Autonoma Mexico, Fac Med, Dept Cirugia, Mexico City 04510, DF, Mexico
|